You are using an older browser version. Please use a supported version for the best MSN experience.

Covid-19: AstraZeneca-Oxford vaccine ‘70% effective’, may get India nod by year-end

Armed with interim findings of the AstraZeneca-Oxford Covid-19 vaccine trials — which showed 70% effectiveness in preventing people from getting infected — Pune-based Serum Institute of India is set to seek emergency regulatory approval and hopes to get a go-ahead by the year-end. The ‘positive’ data raises hopes for a faster rollout of the vaccine in India, as the AstraZeneca data exceeds the 50% primary efficacy endpoint set by the Indian drug regulator DCGI as part of its draft guidelines for Covid-19 vaccines.

UP NEXT

UP NEXT

More From The Times of India

More From The Times of India

image beaconimage beaconimage beacon